Paxman AB (publ)
OTC:PXMBF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (44.7), the stock would be worth $0.64 (82% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 243.5 | $3.5 |
0%
|
| 3-Year Average | 44.7 | $0.64 |
-82%
|
| 5-Year Average | 32.9 | $0.47 |
-86%
|
| Industry Average | 15.5 | $0.22 |
-94%
|
| Country Average | 17.8 | $0.26 |
-93%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
$1.1B
|
/ |
Jan 2026
kr4.3m
|
= |
|
|
$1.1B
|
/ |
Dec 2026
kr39.4m
|
= |
|
|
$1.1B
|
/ |
Dec 2027
kr106.6m
|
= |
|
|
$1.1B
|
/ |
Dec 2028
kr166.2m
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| SE |
P
|
Paxman AB (publ)
OTC:PXMBF
|
1.2B USD | 243.5 | -69.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
171.7B USD | 55.8 | 59.8 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
159.2B USD | 18.9 | 25.2 | |
| US |
|
Stryker Corp
NYSE:SYK
|
126B USD | 23.9 | 38.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
106.8B USD | 18.8 | 23.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
96.2B USD | 26.7 | 33.6 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40.6B EUR | 15.3 | 19.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.3B USD | 25.7 | 43.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.1B USD | 32.9 | 42.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.3B USD | 16.8 | 25.1 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
32.5B USD | 13.4 | 15.3 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 14 |
| Median | 17.8 |
| 70th Percentile | 23.3 |
| Max | 4 325.3 |
Other Multiples
Paxman AB (publ)
Glance View
Paxman AB engages in the research and development of scalp cooling system. The company is headquartered in Karlshamn, Blekinge. The company went IPO on 2017-06-12. The cooling system aims to reduce the risk of hair loss connected with cytostatic treatment of cancer. The firm offers a stand-alone, mobile electric cooling unit, which markets under the name Paxman Scalp Cooler, which is a liquid-based cooling system that cools down the patients scalp through the silicone hat. The product has two versions - for one or two patients to be cooled at once. Each device contains a built-in touch screen with a menu-controlled graphic user interface to monitor the process. The lightweight system enables patient to participate in other activities. The Company’s primary markets are Great Britain, Scandinavian countries, the Netherlands, Belgium and Australia.
